Reinvigoron is a biotechnology company creating systemically-delivered, non-viral DNA therapeutics to treat resistant cancers.
To outsmart cancer, we need therapies that combine optimal delivery, exquisite specificity, modularity, and scalable manufacturing. We are pioneering therapeutics that work intracellularly to reprogram cancer cells into biologic drug factories. Using our proprietary technology, we deliver therapeutic genes via tiny nanoparticle carriers - akin to a microscopic trojan horse - that only activate in cancer cells. We are not just targeting cancer; we are transforming it, unlocking the potential to turn the disease against itself and redefine what’s possible in cancer treatment.
Company Details
- Employees
- 4
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Reinvigoron Theratech Inc. Questions
Reinvigoron Theratech Inc.'s LinkedIn profile is https://www.linkedin.com/company/reinvigoron
Reinvigoron Theratech Inc. has
4 employees.
View email and phone details for 4
employees at Reinvigoron Theratech Inc..
Reinvigoron Theratech Inc.'s industry is
Biotechnology Research
Reinvigoron Theratech Inc.'s top competitors are
Stealth Mode,
Catapult Solutions Group,
Zz Biotech,
Mucolife Therapeutics,
Retex Pharmaceuticals,
Yaso Therapeutics Inc.,
Biolum Sciences,
Sagesse Bio,
Pebble Life Science,
Nanoscope Therapeutics Inc..
Reinvigoron Theratech Inc.'s categories are Biotechnology Research
